Houlihan Lokey Advises Oakley Capital

Houlihan Lokey is pleased to announce that Oakley Capital has acquired Horizons Optical, a healthcare software developer for the design and coating of optical lenses, through Oakley Capital Origin Fund I. The transaction was completed on 12 April 2024.

Based in London, Oakley Capital specialises in European middle-market growth capital and buyouts. The fund focuses its investments primarily in the technology, consumer, education, and business services sectors. Oakley Capital will look to expand Horizons Optical’s international growth plans, winning over market share abroad by leveraging on its innovative offering and bespoke eyecare solutions. This investment marks Oakley Capital’s sixth deal in Spain, further strengthening its commitment to Iberia.

Born in 2017 and based in Barcelona, Horizons Optical develops proprietary and patented software to produce tailored optical progressive lenses to correct several eye conditions, including short-, mid-, and far-sightedness, as well as astigmatism. The company has grown to be one of the preferred global tech partners of independent lens manufacturers, positioning its lenses in high-value-added segments within the optical industry. The company also offers hardware solutions to optical retailers, allowing for accurate facial scans and the measurement of relevant parameters for the manufacturing of lenses and frames.

Alongside Oakley Capital, Horizons Optical can look to fulfil the potential of its disruptive approach to the optical industry and accelerate its international growth plans. Oakley Capital will also support Horizons Optical through investments in R&D and sales and marketing, ensuring sustainable growth as an innovator and disruptor in its core markets.

RELATED: Healthcare, Financial Sponsors Coverage, Corporate Finance